Stay updated with breaking news from Balance Sheet Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Company plans to hold a conference call in early December to provide a comprehensive RP1 skin cancer program update including:
G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights ...
01.11.2023 - 9.1% Digital Revenue Growth with Digital Accounting for 18.6% of Quarterly Revenue;Third Quarter Net Loss of $67.5 Million, Inclusive of $88.8 million of Non-Cash Impairment Losses, and Adjusted EBITDA of $5.5 Million  Conference Call and ...
Year-to-date Gross Margin of 32+%, highest level since 2011 ...
01.11.2023 - Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced recent business highlights, including progress on its strategic transformation and a corresponding restructuring of operations and workforce reduction, and ...